Designed to streamline the challenging processes of organoid generation, in vitro drug screening, and imaging, the NLS™ offers a sophisticated alternative for expanding preclinical drug testing methods beyond traditional 2D cell cultures and animal models.

NLS™ is a plug-and-play solution adept at managing everything from initial iPSC differentiation to organoid culture maintenance, perfectly aligning with standard imaging techniques for phenotypic screening. For those keen to explore how NLS™ can cater to specific organoid types, please reach out to discover more about its versatile applications.

This OoC platform stands out from traditional automated cell culture systems by offering substantial cost benefits. It competently processes large organoid samples and reduces material use, thus significantly cutting down on capital expenditures relative to conventional robotic systems. This makes the NLS™ platform a cost-effective choice for diverse drug and chemical screening applications.

Boost your research and development capabilities with the NLS™, designed to minimize manual workload and maximize effectiveness. This allows your team to dedicate more time to innovation, speeding up the creation of groundbreaking therapies. For additional details on how the NLS™ can support your R&D objectives, please contact us.